The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis
Open accessAbstract
Oxidation products of low-density lipoproteins have been suggested to promote inflammation during atherogenesis, and reticulocyte-type 15-lipoxygenase has been implicated to mediate this oxidation. In addition, the 5-lipoxygenase cascade leads to formation of leukotrienes, which exhibit strong proinflammatory activities in cardiovascular tissues. Here, we studied both lipoxygenase pathways in human atherosclerosis. The 5-lipoxygenase pathway was abundantly expressed in arterial walls of patients afflicted with various lesion stages of atherosclerosis of the aorta and of coronary and carotid arteries. 5-lipoxygenase localized to macrophages, dendritic cells, foam cells, mast cells, and neutrophilic granulocytes, and the number of 5-lipoxygenase expressing cells markedly increased in advanced lesions. By contrast, reticulocyte-type 15-lipoxygenase was expressed at levels that were several orders of magnitude lower than 5-lipoxygenase in both normal and diseased arteries, and its expression could not be related to lesion pathology. Our data support a model of atherogenesis in which 5-lipoxygenase cascade-dependent inflammatory circuits consisting of several leukocyte lineages and arterial wall cells evolve within the blood vessel wall during critical stages of lesion development. They raise the possibility that antileukotriene drugs may be an effective treatment regimen in late-stage disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,533
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Self-citationBook ReviewAmbulatory Pediatric Care
Steinberg, J. B. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901053200122 · Cited by 2,108
The Pathogenesis of Atherosclerosis: (First of Two Parts)
Ross, R., & Glomset, J. A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608122950707 · Cited by 2,014
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,424
The oxidation hypothesis of atherosclerosis
Witztum, J. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92346-9 · Cited by 1,389
Dahlén, S. E., Björk, J., Hedqvist, P., Arfors, K. E., Hammarström, S., Lindgren, J. A., & Samuelsson, B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3887 · Cited by 1,019
Self-citationA G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Characterization of the human cysteinyl leukotriene CysLT1 receptor
Lynch, K. R., O'Neill, G. P., Liu, Q., Im, D.-S., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z., et al. (1999) · Nature · doi:10.1038/21658 · Cited by 965
Valladeau, J., Ravel, O., Dezutter-Dambuyant, C., Moore, K., Kleijmeer, M., Liu, Y., Duvert-Frances, V., Vincent, C., Schmitt, D., Davoust, J., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80160-0 · Cited by 962
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
Drazen, J. M., Israel, E., & O'Byrne, P. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400306 · Cited by 820
Gown, A. M., Tsukada, T., & Ross, R. (1986) · PubMed · Cited by 676
Characterization of the Human Cysteinyl Leukotriene 2 Receptor
Heise, C. E., O'Dowd, B. F., Figueroa, D. J., Sawyer, N., Nguyen, T., Im, D.-S., Stocco, R., Bellefeuille, J. N., Abramovitz, M., Cheng, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003490200 · Cited by 658
A Second Leukotriene B4 Receptor, Blt2
Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., & Shimizu, T. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.421 · Cited by 538
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523
Robbiani, D. F., Finch, R. A., Jäger, D., Muller, W. A., Sartorelli, A. C., & Randolph, G. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00179-3 · Cited by 454
Mehrabian, M., Allayee, H., Wong, J., Shih, W., Wang, X.-P., Shaposhnik, Z., Funk, C. D., & Lusis, A. J. (2002) · Circulation Research · doi:10.1161/01.res.0000028008.99774.7f · Cited by 422
Methyl‐CpG‐binding proteins: Targeting specific gene repression
Ballestar, E., & Wolffe, A. P. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01869.x · Cited by 408
de Saint-Vis, B., Vincent, J., Vandenabeele, S., Vanbervliet, B., Pin, J.-J., Aït-Yahia, S., Patel, S., Mattei, M.-G., Banchereau, J., Zurawski, S., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80615-9 · Cited by 399
Lipid mediator networks in cell signaling: update and impact of cytokines 1
Serhan, C. N., Haeggström, J. Z., & Leslie, C. C. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.10.8751717 · Cited by 394
Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase.
Conrad, D. J., Kuhn, H., Mulkins, M., Highland, E., & Sigal, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.217 · Cited by 381
Ylä-Herttuala, S., Rosenfeld, M. E., Parthasarathy, S., Sigal, E., Särkioja, T., Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115111 · Cited by 379
Huang, A. J., Manning, J. E., Bandak, T. M., Ratau, M. C., Hanser, K. R., & Silverstein, S. C. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.6.1371 · Cited by 339
McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.7.2204 · Cited by 281
Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques.
Folcik, V. A., Nivar-Aristy, R. A., Krajewski, L. P., & Cathcart, M. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118062 · Cited by 252
Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice
Aiello, R. J., Bourassa, P.-A., Lindsey, S., Weng, W., Freeman, A., & Showell, H. J. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.105593 · Cited by 247
Harats, D., Shaish, A., George, J., Mulkins, M., Kurihara, H., Levkovitz, H., & Sigal, E. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2100 · Cited by 238
Michelassi, F., Landa, L., Hill, R. D., Lowenstein, E., Watkins, W. D., Petkau, A. J., & Zapol, W. M. (1982) · Science · doi:10.1126/science.6808665 · Cited by 217
Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey
Smedegård, G., Hedqvist, P., Dahlén, S.-E., Revenäs, B., Hammarström, S., & Samuelsson, B. (1982) · Nature · doi:10.1038/295327a0 · Cited by 204
Self-citation12/15-Lipoxygenase Gene Disruption Attenuates Atherogenesis in LDL Receptor–Deficient Mice
George, J., Afek, A., Shaish, A., Levkovitz, H., Bloom, N., Cyrus, T., Zhao, L., Funk, C. D., Sigal, E., & Harats, D. (2001) · Circulation · doi:10.1161/hc3901.095772 · Cited by 194
Involvement of 15-lipoxygenase in early stages of atherogenesis.
Kühn, H., Belkner, J., Zaiss, S., Fährenklemper, T., & Wohlfeil, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.6.1903 · Cited by 193
Self-citationLeukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro.
Burke, J. A., Levi, R., Guo, Z. G., & Corey, E. J. (1982) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33042-9 · Cited by 180
The Oxidation of Lipoproteins by Monocytes-Macrophages
Chisolm, G. M., Hazen, S. L., Fox, P. L., & Cathcart, M. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.25959 · Cited by 174
In vivo action of 15-lipoxygenase in early stages of human atherogenesis.
Kühn, H., Heydeck, D., Hugou, I., & Gniwotta, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119253 · Cited by 168
Self-citationCell-mediated immunity in atherosclerosis
Hansson, G. K. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00009 · Cited by 167
Cardiovascular disease burden increases, NIH funding decreases
Breslow, J. L. (1997) · Nature Medicine · doi:10.1038/nm0697-600 · Cited by 133
Atkinson, J. B., Harlan, C. W., Harlan, G., & Virmani, R. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90271-2 · Cited by 124
Differential Leukotriene Constrictor Responses in Human Atherosclerotic Coronary Arteries
Allen, S. P., Dashwood, M. R., Morrison, K. J. M., & Yacoub, M. H. (1998) · Circulation · doi:10.1161/01.cir.97.24.2406 · Cited by 112
Spanbroek, R., Hildner, M., Köhler, A., Müller, A., Zintl, F., Kühn, H., Rådmark, O., Samuelsson, B. O., & Habenicht, A. J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091076998 · Cited by 111
Self-citationZhao, L., Cuff, C. A., Moss, E., Wille, U., Cyrus, T., Klein, E. A., Praticò, D., Rader, D. J., Hunter, C. A., Puré, E., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205738200 · Cited by 109
Nomoto, A., Mutoh, S., Hagihara, H., & Yamaguchi, I. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90083-4 · Cited by 106
Datta, Y. H., Romano, M., Jacobson, B. C., Golan, D. E., Serhan, C. N., & Ewenstein, B. M. (1995) · Circulation · doi:10.1161/01.cir.92.11.3304 · Cited by 102
The role of 15-lipoxygenase in atherogenesis: pro- and antiatherogenic actions
Hartmut, K., & Chan, L. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199704000-00009 · Cited by 99
Katsuda, S., Coltrera, M. D., Ross, R., & Gown, A. M. (1993) · PubMed · Cited by 92
Leukotrienes stimulate initiation of DNA synthesis in cultured arterial smooth muscle cells
Palmberg, L., Claesson, H., & Thyberg, J. (1987) · Journal of Cell Science · doi:10.1242/jcs.88.2.151 · Cited by 82
Sjöström, M., Jakobsson, P., Heimbürger, M., Palmblad, J. E. W., & Haeggström, J. Z. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02142.x · Cited by 82
Induction of 15-Lipoxygenase mRNA and Protein in Early Atherosclerotic Lesions
Hiltunen, T. P., Luoma, J. S., Nikkari, T., & Ylä‐Herttuala, S. (1995) · Circulation · doi:10.1161/01.cir.92.11.3297 · Cited by 73
5-Lipoxygenase expression in Langerhans cells of normal human epidermis
Spanbroek, R., Stark, H., Janssen-Timmen, U., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.663 · Cited by 64
Self-citationWissler, R. W. (1995) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199512000-00006 · Cited by 58
Heimbürger, M., & Palmblad, J. E. W. (1996) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1996.tb08302.x · Cited by 45
Cited by
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
Bhattacharyya, A., Chattopadhyay, R., Mitra, S., & Crowe, S. E. (2014) · Physiological Reviews · doi:10.1152/physrev.00040.2012 · Cited by 2,484
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,414
Peters-Golden, M., & Henderson, W. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071371 · Cited by 1,013
Metadata
- Authors
- Spanbroek, R., Gräbner, R., Lötzer, K., Hildner, M., Urbach, A., Rühling, K., Moos, M. P. W., Kaiser, B., Cohnert, T. U., Wahlers, T., Zieske, A., Plenz, G., Robenek, H., Salbach, P., Kühn, H., Rådmark, O., Samuelsson, B., & Habenicht, A. J. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-01-27
- Volume
- 100
- Issue
- 3
- Pages
- 1238-1243
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2032255457
- Cited by
- 458
- References
- 53
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.